Technical Analysis for GLUE - Monte Rosa Therapeutics, Inc.

Grade Last Price % Change Price Change
B 6.70 4.52% 0.29
GLUE closed up 4.52 percent on Monday, March 18, 2024, on 1.16 times normal volume.
Earnings due: Mar 26
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup 4.52%
20 DMA Support Bullish 10.02%
Wide Bands Range Expansion 0.75%
Wide Bands Range Expansion 10.20%
Shooting Star Candlestick Bearish 7.72%
Wide Bands Range Expansion 7.72%
Wide Bands Range Expansion 6.52%
Gapped Up Strength 6.52%

   Recent Intraday Alerts

Alert Time
Upper Bollinger Band Resistance about 12 hours ago
Rose Above Upper Bollinger Band about 13 hours ago
Rose Above Previous Day's High about 13 hours ago
Up 5% about 13 hours ago
60 Minute Opening Range Breakout about 14 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Monte Rosa Therapeutics, Inc. Description

Monte Rosa Therapeutics is a biotechnology company developing a portfolio of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins. The company has developed a proprietary protein degradation platform, called QuEEN™, that enables it to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates that are designed to eliminate therapeutically relevant proteins in a highly selective manner. The company’s drug discovery platform combines diverse and proprietary chemical libraries of small molecule protein degraders with in-house proteomics, structural biology, machine learning-based target selection and computational chemistry capabilities to predict and obtain protein degradation profiles. Monte Rosa was launched from founding investor Versant Ventures’ Ridgeline Discovery Engine and is headquartered in Boston, Mass., with research operations in both Boston and Basel, Switzerland.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Drug Discovery Machine Learning Proteomics

Is GLUE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.8334
52 Week Low 2.44
Average Volume 143,586
200-Day Moving Average 5.52
50-Day Moving Average 5.71
20-Day Moving Average 6.12
10-Day Moving Average 6.23
Average True Range 0.60
RSI (14) 58.51
ADX 26.49
+DI 29.53
-DI 14.46
Chandelier Exit (Long, 3 ATRs) 5.41
Chandelier Exit (Short, 3 ATRs) 6.70
Upper Bollinger Bands 6.91
Lower Bollinger Band 5.33
Percent B (%b) 0.86
BandWidth 25.80
MACD Line 0.26
MACD Signal Line 0.23
MACD Histogram 0.0281
Fundamentals Value
Market Cap 335.54 Million
Num Shares 50.1 Million
EPS -2.69
Price-to-Earnings (P/E) Ratio -2.49
Price-to-Sales 0.00
Price-to-Book 1.27
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.78
Resistance 3 (R3) 7.76 7.37 7.60
Resistance 2 (R2) 7.37 7.10 7.39 7.54
Resistance 1 (R1) 7.04 6.93 7.21 7.06 7.48
Pivot Point 6.65 6.65 6.74 6.67 6.65
Support 1 (S1) 6.32 6.38 6.49 6.34 5.92
Support 2 (S2) 5.93 6.21 5.95 5.86
Support 3 (S3) 5.60 5.93 5.80
Support 4 (S4) 5.62